ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Expert Opinion on Drug Metabolism & Toxicology

• Publication date

  2010-09-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/17425255.2010.510832PMID 20843279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenetic regulation of multidrug resistance 1 gene expression: profiling CpG methylation status using bisulphite sequencing.

  2010cited by this paper
• Opioids Activate Brain Analgesic Circuits Through Cytochrome P450/Epoxygenase Signaling

  2010cited by this paper
• Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson disease.

  2010cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Transcriptional regulation of cholesterol 24-hydroxylase by histone deacetylase inhibitors.

  2009cited by this paper
• Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells.

  2009cited by this paper
• Association of a polymorphism in the ABCB1 gene with Parkinson's disease.

  2009cited by this paper
• Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration.

  2009cited by this paper
• ABCG2: a perspective.

  2009cited by this paper
• ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ1–40 Peptides

  2009cited by this paper
• Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human.

  2009cited by this paper
• MDR1 variants and risk of Parkinson disease

  2009cited by this paper
• Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral Function

  2009influential reference
• P-Glycoprotein and Breast Cancer Resistance Protein Restrict Apical-to-Basolateral Permeability of Human Brain Endothelium to Amyloid-β

  2009cited by this paper
• Brain Drug-Metabolizing Cytochrome P450 Enzymes are Active In Vivo, Demonstrated by Mechanism-Based Enzyme Inhibition

  2009cited by this paper
• ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNS

  2008influential reference
• ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrier

  2008influential reference
• Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging : A possible role in progressive neurodegeneration

  2008cited by this paper
• Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain.

  2008cited by this paper
• Differential expression of the multidrug resistance‐related proteins ABCb1 and ABCc1 between blood‐brain interfaces

  2008cited by this paper
• Integration of metabolism and inflammation by lipid-activated nuclear receptors

  2008cited by this paper
• Role of CYP1B1 in glaucoma.

  2008cited by this paper
• Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood-brain barrier.

  2008cited by this paper
• Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample

  2008cited by this paper
• Metabolization of Porphyrinogenic Agents in Brain: Involvement of the Phase I Drug Metabolizing System. A Comparative Study in Liver and Kidney

  2007cited by this paper
• MDR1‐P‐Glycoprotein (ABCB1) Mediates Transport of Alzheimer’s Amyloid‐β Peptides—Implications for the Mechanisms of Aβ Clearance at the Blood–Brain Barrier

  2007cited by this paper
• Mammalian cytochromes P450--importance of tissue specificity.

  2007cited by this paper
• Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system.

  2007cited by this paper
• Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues

  2007cited by this paper
• Metabolism of DDT in Different Tissues of Young Rats

  2006cited by this paper
• The genetics of Parkinson disease: implications for neurological care

  2006cited by this paper
• In Situ Localization of P-glycoprotein (ABCB1) in Human and Rat Brain

  2006cited by this paper
• Vascular colocalization of P‐glycoprotein, multidrug‐resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies

  2006cited by this paper
• Induction of phase I, II and III drug metabolism/transport by xenobiotics

  2005cited by this paper
• P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.

  2005cited by this paper
• Pesticides and Parkinson’s Disease—Is There a Link?

  2005cited by this paper
• Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis.

  2005cited by this paper
• Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier.

  2004cited by this paper
• Lidocaine: a foot in the door of the inner vestibule prevents ultra-slow inactivation of a voltage-gated sodium channel.

  2004cited by this paper
• CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease

  2004cited by this paper
• The Unique Regulation of Brain Cytochrome P450 2 (CYP2) Family Enzymes by Drugs and Genetics

  2004influential reference
• The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease.

  2004influential reference
• Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and1B1

  2004cited by this paper
• MDR1, the blood–brain barrier transporter, is associated with Parkinson’s disease in ethnic Chinese

  2004cited by this paper
• Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting

  2004cited by this paper
• Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain.

  2004cited by this paper
• Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies.

  2004cited by this paper
• CYP1A1 and CYP1B1 in blood-brain interfaces: CYP1A1-dependent bioactivation of 7,12-dimethylbenz(a)anthracene in endothelial cells.

  2003cited by this paper
• RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

  2003cited by this paper
• Constitutive and inducible levels of CYP1A1 and CYP1A2 in rat cerebral cortex and cerebellum

  2003influential reference
• Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.

  2003influential reference
• Cerebral amyloid angiopathy: Pathogenesis and effects on the ageing and Alzheimer brain

  2003cited by this paper
• Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

  2003cited by this paper
• Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.

  2003cited by this paper
• Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics

  2003influential reference
• Expression and functional characterization of ABCG2 in brain endothelial cells and vessels

  2003cited by this paper
• Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR.

  2003cited by this paper
• Molecular and functional MDR1‐Pgp and MRPs expression in human glioblastoma multiforme cell lines

  2002cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• Drug-metabolizing cytochrome P450s in the brain.

  2002cited by this paper
• Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.

  2002cited by this paper
• Localisation of breast cancer resistance protein in microvessel endothelium of human brain

  2002cited by this paper
• Progesterone oxidation by cytochrome P450 2D isoforms in the brain.

  2001cited by this paper
• beta-Amyloid efflux mediated by p-glycoprotein.

  2001cited by this paper
• β‐Amyloid efflux mediated by p‐glycoprotein

  2001cited by this paper
• Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects

  2001cited by this paper
• Overexpression of Multiple Drug Resistance Genes in Endothelial Cells from Patients with Refractory Epilepsy

  2001cited by this paper
• Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

  2001cited by this paper
• Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells.

  2001cited by this paper
• Neurotoxicity of the organochlorine insecticide heptachlor to murine striatal dopaminergic pathways.

  2001cited by this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein

  2001cited by this paper
• Multiple forms of cytochrome P450 and associated monooxygenase activities in human brain mitochondria.

  2000cited by this paper
• Organochlorine insecticides in substantia nigra in Parkinson's disease.

  2000cited by this paper
• Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the expression of cytochrome P450 1A1, the aryl hydrocarbon receptor, and the aryl hydrocarbon receptor nuclear translocator in rat brain and pituitary.

  2000cited by this paper
• Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.

  2000cited by this paper
• Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment.

  2000cited by this paper
• Evidence for the activation of organophosphate pesticides by cytochromes P450 3A4 and 2D6 in human liver microsomes.

  2000influential reference
• Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain.

  1999cited by this paper
• Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan.

  1999cited by this paper
• Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease.

  1999cited by this paper
• Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation

  1998cited by this paper
• Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization.

  1997influential reference
• Radical cation intermediates in N-dealkylation reactions.

  1995cited by this paper
• Rat brain cytochrome P450. Reassessment of monooxygenase activities and cytochrome P450 levels.

  1995cited by this paper
• Progress in psychiatry (2).

  1993cited by this paper
• Progress in psychiatry (1)

  1993cited by this paper
• Cytochrome P-450 in the brain. Potential evolutionary and therapeutic relevance of localization of drug-metabolizing enzymes.

  1992cited by this paper
• Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.

  1991cited by this paper
• Morphine formation from codeine in rat brain: a possible mechanism of codeine analgesia.

  1990cited by this paper
• Astrocytes as a primary locus for the conversion MPTP into MPP+

  1989cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper
• Quantitative measurement of cerebral cytochrome P-450 by second derivative spectrophotometry.

  1987cited by this paper
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

  1987cited by this paper
• Subcellular distribution of cytochrome P-450 in the brain.

  1986cited by this paper
• MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.

  1984cited by this paper
• 2-Hydroxylation of estrogens in the brain participates in the initiation of the preovulatory LH surge in the rat.

  1980cited by this paper
• Immunological comparison of hepatic and extrahepatic cytochromes P-450.

  1979cited by this paper
• Characterization of cytochrome P-450-dependent aminopyrine N-demethylase in rat brain: comparison with hepatic aminopyrine N-demethylation.

  1979cited by this paper

• Integrated Computational Biology Revealed Ellagic Acid Exerts Antioxidant and Anticancer Activities Through Inhibition of ROS-induced JNK/p38 MAPK Kinase Pathway

  2025cites this paper
• Gatekeeper of the brain: unraveling the role of ABCB1 in Parkinson’s disease progression and therapy

  2025cites this paper
• Advanced intranasal peptide delivery systems for improved management of Alzheimer's disease.

  2025cites this paper
• Exploring bat-inspired cyclic tryptophan diketopiperazines as ABCB1 Inhibitors

  2024cites this paper
• Development of Natural-Product-Inspired ABCB1 Inhibitors Through Regioselective Tryptophan C3-Benzylation.

  2024cites this paper
• The Association of Gene Polymorphisms Linked to Caffeine Use with Athletic Performance

  2023cites this paper
• 1,2-Dehydropyrrolizidine Alkaloids: Their Potential as a Dietary Cause of Sporadic Motor Neuron Diseases.

  2022cites this paper
• DEC1 negatively regulates CYP2B6 expression by binding to the CYP2B6 promoter region ascribed to IL-6-induced downregulation of CYP2B6 expression in HeLa cells

  2021cites this paper
• Glutamate affects the CYP1B1- and CYP2U1-mediated hydroxylation of arachidonic acid metabolism via astrocytic mGlu5 receptor.

  2019cites this paper
• ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas

  2019cites this paper
• Investigating Maternal Brain Alterations in Preeclampsia: the Need for a Multidisciplinary Effort

  2019cites this paper
• ABC transporters in neurological disorders: an important gateway for botanical compounds mediated neuro-therapeutics.

  2019cites this paper
• In vitro and in vivo models of BBB to evaluate brain targeting drug delivery

  2019cites this paper
• ABCB1: is there a role in the drug treatment of Parkinson’s disease?

  2018cites this paper
• Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells

  2018cites this paper
• Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms

  2018cites this paper
• β-Naphtoflavone and Ethanol Induce Cytochrome P450 and Protect towards MPP+ Toxicity in Human Neuroblastoma SH-SY5Y Cells

  2018cites this paper
• In Vitro Cell Models of the Human Blood-Brain Barrier: Demonstrating the Beneficial Influence of Shear Stress on Brain Microvascular Endothelial Cell Phenotype

  2018cites this paper
• Are the Current Guidelines on Caffeine Use in Sport Optimal for Everyone? Inter-individual Variation in Caffeine Ergogenicity, and a Move Towards Personalised Sports Nutrition

  2017cites this paper
• Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery.

  2017cites this paper
• Role of neural barriers in the pathogenesis and outcome of Streptococcus pneumoniae meningitis

  2017cites this paper
• Characterizing the Gender Differences of Multidrug-resistance Peptide (MRP) Transporter Expression in Mouse Blood-brain Interfaces

  2017cites this paper
• [Drug glucuronidation and disposition in brain].

  2016cites this paper
• Characterization of passive permeability at the blood–tumor barrier in five preclinical models of brain metastases of breast cancer

  2016cites this paper
• β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function

  2016cites this paper
• A nutritional supplement containing lactoferrin stimulates the immune system, extends lifespan, and reduces amyloid β peptide toxicity in Caenorhabditis elegans

  2016cites this paper
• Species Differences and Impact of Disease State on BBB

  2015cites this paper
• Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products

  2015cites this paper
• Sex hormones regulate cerebral drug metabolism via brain miRNAs: down‐regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol

  2015cites this paper
• Regulation of ABC transporters at the blood–brain barrier

  2015cites this paper
• Regulation of cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol with propranolol and nicotine

  2015cites this paper
• Subacute nicotine co-exposure has no effect on 2,2',3,5',6- pentachlorobiphenyl disposition but alters hepatic cytochrome P450 expression in the male rat.

  2015cites this paper
• Drug Transporters in the Central Nervous System

  2015cites this paper
• Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report

  2015cites this paper
• Disease Influence on BBB Transport in Neurodegenerative Disorders

  2014cites this paper
• In Vitro Models of CNS Barriers

  2014cites this paper
• PET Imaging of ABC Transporters in the BBB

  2014cites this paper
• T-Lymphocyte Deficiency Exacerbates Behavioral Deficits in the 6-OHDA Unilateral Lesion Rat Model for Parkinson’s Disease

  2014cites this paper
• Improved brain uptake of peptide-based CNS drugs via alternative routes of administrations of its nanocarrier delivery systems: a promising strategy for CNS targeting delivery of peptides

  2014influential citation
• Occurrence, distribution and potential actions of CYP2D6 in the brain

  2014cites this paper
• Improving brain drug targeting through exploitation of the nose-to-brain route: a physiological and pharmacokinetic perspective.

  2014cites this paper
• AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.

  2014cites this paper
• The endogenous substrates of brain CYP2D.

  2014cites this paper
• Extrahepatic targets and cellular reactivity of drug metabolites.

  2014cites this paper
• CYP2D6 : clinical implications in neuropsychiatry

  2014cites this paper
• Cytochrome P450-mediated metabolism in brain: functional roles and their implications

  2013cites this paper
• Nanotechnology: Toxicologic Pathology

  2013cites this paper
• DMD051359 1187..1194

  2013cites this paper
• Heinz Lehmann Award paper Cytochrome P 450 – mediated drug metabolism in the brain

  2013cites this paper
• Confounding parameters in preclinical assessment of blood-brain barrier permeation: an overview with emphasis on species differences and effect of disease states.

  2013cites this paper
• Blood–brain barrier structure and function and the challenges for CNS drug delivery

  2013cites this paper
• Cytochrome P450-mediated drug metabolism in the brain.

  2013cites this paper
• Genetics of Epilepsy and Refractory Epilepsy

  2013cites this paper
• Differential Expression of Human Cytochrome P450 Enzymes from the CYP3A Subfamily in the Brains of Alcoholic Subjects and Drug-Free Controls

  2013cites this paper
• The Expression and Regulation of CYP2D in a Monkey Model of Ethanol and Nicotine Exposure

  2013cites this paper
• Genetic Dissection of Strain Dependent Paraquat-induced Neurodegeneration in the Substantia Nigra Pars Compacta

  2012cites this paper
• Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics

  2012cites this paper
• In vitro blood-brain barrier models: current and perspective technologies.

  2012cites this paper
• Barriers in the developing brain and Neurotoxicology.

  2012cites this paper
• Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.

  2012cites this paper
• Inhibition of Brain CYP2D Lowers Codeine-induced Analgesia in Rats

  2012cites this paper
• Genetic variation in CYP2D6 impacts neural activation during cognitive tasks in humans

  2012cites this paper
• HIF-1 at the Blood-Brain Barrier: A Mediator of Permeability?

  2012cites this paper
• 2 The Blood-Brain Barrier in Epilepsy

  2011cites this paper
• Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.

  2011cites this paper
• The Blood-Brain Barrier in Epilepsy

  2011cites this paper
• AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011

  2011cites this paper
• Drug Transport and Metabolism in the Blood–Brain Barrier

  2011cites this paper
• Direct evidence of abca1-mediated efflux of cholesterol at the mouse blood–brain barrier

  2011cites this paper
• Central Lancashire Online Knowledge (CLoK)

  year unknowncites this paper